ClearPoint Neuro第一季度每股收益$（0.22）错过$（0.16）估计，销售额848万美元，超过820万美元估计

ClearPoint Neuro (NASDAQ: CLPT) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.16) by 37.5 percent. This is a 37.5 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $8.48 million which beat the analyst consensus estimate of $8.20 million by 3.48 percent. This is a 11.07 percent increase over sales of $7.64 million the same period last year.